Through a variety of mechanisms, glucocorticoids exert potent growth s
uppressing effects. Primarily through the use of inhaled corticosteroi
d preparations to treat asthma, the number of children exposed to exog
enous glucocorticoids is rapidly increasing. Although growth failure i
s commonly experienced by children receiving long term oral glucocorti
coid therapy, the effect of inhaled corticosteroids on growth remains
an unresolved and controversial issue. In situations where glucocortic
oid therapy and its attendant adverse effects on growth are unavoidabl
e, inhibitory effects of glucocorticoids on pulsatile growth hormone s
ecretion, insulin like growth factor-1 bioactivity, and collagen synth
esis could theoretically be compensated for by exogenous growth hormon
e therapy. This article reviews the pathophysiology of growth suppress
ion by glucocorticoids, the information currently available regarding
the effects of chronic inhaled corticosteroids on growth, and the effe
ctiveness of growth hormone therapy in reversing glucocorticoid-induce
d growth failure.